COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD (ULT01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02576626
Recruitment Status : Completed
First Posted : October 15, 2015
Last Update Posted : October 11, 2017
University Medical Center Groningen
Information provided by (Responsible Party):
Wouter H. van Geffen, Groningen Research Institute for Asthma and COPD

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 29, 2017
Actual Study Completion Date : September 29, 2017